$TWST
Twist Bioscience Corp Stock $twst

$twst Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-Q Financial Statement

#000162828023002560 Filed on February 07, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2021 Q4
Revenue	$60.18M	$54.24M	$42.02M
YoY Change	25.04%	29.09%	49.21%
Cost Of Revenue	$41.67M	$29.44M	$27.06M
YoY Change	40.23%	8.82%	48.97%
Gross Profit	$18.51M	$24.80M	$14.96M
YoY Change	0.53%	65.76%	49.63%
Gross Profit Margin	30.76%	45.72%	35.61%
Selling, General & Admin	$53.97M	$42.32M	$51.10M
YoY Change	-0.06%	-17.17%	77.47%
% of Gross Profit	291.53%	170.65%	341.52%
Research & Development	$27.38M	$31.24M	$22.63M
YoY Change	-12.33%	38.06%	61.64%
% of Gross Profit	147.91%	125.97%	151.25%
Depreciation & Amortization	$7.028M	$5.292M	$3.150M
YoY Change	77.12%	68.0%	49.22%
% of Gross Profit	37.97%	21.34%	21.05%
Operating Expenses	$81.34M	$73.57M	$73.73M
YoY Change	-4.56%	-0.22%	72.29%
Operating Profit	-$61.64M	-$44.63M	-$55.94M
YoY Change	1.37%	-20.22%	70.59%
Interest Expense	$2.000K	$1.000K	$26.00K
YoY Change	-93.1%	-96.15%	-77.97%
% of Operating Profit
Other Income/Expense, Net	-$305.0K	-$157.0K	-$156.0K
YoY Change	24.49%	0.64%	102.6%
Pretax Income	-$58.48M	-$41.75M	-$55.97M
YoY Change	-3.84%	-25.41%	70.35%
Income Tax	$676.0K	$76.00K	-$10.41M
% Of Pretax Income
Net Earnings	-$59.16M	-$41.82M	-$45.56M
YoY Change	-2.49%	-8.21%	38.49%
Net Earnings / Revenue	-98.3%	-77.1%	-108.44%
Basic Earnings Per Share	-$1.04	-$0.74	-$0.91
Diluted Earnings Per Share	-$1.04	-$0.74	-$912.9K
COMMON SHARES
Basic Shares Outstanding	56.86M shares	56.57M shares	49.63M
Diluted Shares Outstanding	56.78M shares	56.44M shares	49.91M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$387.7M	$438.7M	$301.9M
YoY Change	-32.45%	45.34%	-48.6%
Cash & Equivalents	$315.2M	$316.7M	$191.6M
Short-Term Investments	$72.46M	$122.0M	$110.2M
Other Short-Term Assets	$13.50M	$14.12M	$10.04M
YoY Change	22.21%	40.63%	22.4%
Inventory	$39.92M	$44.60M	$40.24M
Prepaid Expenses
Receivables	$48.19M	$44.44M	$32.87M
Other Receivables	$5.314M	$5.254M	$5.834M
Total Short-Term Assets	$489.3M	$541.9M	$385.0M
YoY Change	-26.36%	40.74%	-39.31%
LONG-TERM ASSETS
Property, Plant & Equipment	$146.5M	$144.9M	$65.14M
YoY Change	59.6%	122.38%	9.47%
Goodwill	$85.81M	$85.81M	$84.24M
YoY Change	0.16%	1.86%
Intangibles
YoY Change
Long-Term Investments			$106.8M
YoY Change
Other Assets	$2.201M	$2.922M	$7.425M
YoY Change	-68.11%	-60.65%	72.67%
Total Long-Term Assets	$364.7M	$368.1M	$401.2M
YoY Change	2.07%	-8.24%	515.28%
TOTAL ASSETS
Total Short-Term Assets	$489.3M	$541.9M	$385.0M
Total Long-Term Assets	$364.7M	$368.1M	$401.2M
Total Assets	$853.9M	$910.0M	$786.2M
YoY Change	-16.42%	15.75%	12.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.24M	$20.11M	$23.07M
YoY Change	-21.28%	-12.83%	159.25%
Accrued Expenses	$11.16M	$10.40M	$11.69M
YoY Change	-30.02%	-11.02%	-45.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$72.11M	$83.84M	$80.03M
YoY Change	-14.8%	4.75%	115.73%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$60.00K	$60.00K	$19.67M
YoY Change	-99.26%	-99.69%	-17.7%
Total Long-Term Liabilities	$60.00K	$60.00K	$19.67M
YoY Change	-99.26%	-99.69%	-19.71%
TOTAL LIABILITIES
Total Short-Term Liabilities	$72.11M	$83.84M	$80.03M
Total Long-Term Liabilities	$60.00K	$60.00K	$19.67M
Total Liabilities	$150.0M	$163.6M	$160.0M
YoY Change	-5.23%	2.29%	159.72%
SHAREHOLDERS EQUITY
Retained Earnings	-$929.4M	-$870.2M	-$656.1M
YoY Change	29.66%	32.63%
Common Stock	$0.00	$0.00	$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$703.9M	$746.3M	$626.2M
YoY Change
Total Liabilities & Shareholders Equity	$853.9M	$910.0M	$786.2M
YoY Change	-16.42%	15.75%	12.37%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2021 Q4
OPERATING ACTIVITIES
Net Income	-$59.16M	-$41.82M	-$45.56M
YoY Change	-2.49%	-8.21%	38.49%
Depreciation, Depletion And Amortization	$7.028M	$5.292M	$3.150M
YoY Change	77.12%	68.0%	49.22%
Cash From Operating Activities	-$44.29M	-$54.07M	-$46.65M
YoY Change	4.6%	15.9%	87.12%
INVESTING ACTIVITIES
Capital Expenditures	$9.053M	$11.82M	$12.78M
YoY Change	-128.32%	-7.5%	252.25%
Acquisitions		$0.00	$8.160M
YoY Change		-100.0%
Other Investing Activities	$50.21M	$4.853M	-$213.8M
YoY Change	168.86%	-102.27%	405.55%
Cash From Investing Activities	$41.16M	-$6.971M	-$226.6M
YoY Change	-409.61%	-96.92%	393.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	1.525M	-$395.0K	-1.011M
YoY Change	-99.44%	-60.93%	-100.31%
NET CHANGE
Cash From Operating Activities	-44.29M	-$54.07M	-46.65M
Cash From Investing Activities	41.16M	-$6.971M	-226.6M
Cash From Financing Activities	1.525M	-$395.0K	-1.011M
Net Change In Cash	-1.603M	-$61.17M	-274.2M
YoY Change	-100.74%	-77.69%	-207.06%
FREE CASH FLOW
Cash From Operating Activities	-$44.29M	-$54.07M	-$46.65M
Capital Expenditures	$9.053M	$11.82M	$12.78M
Free Cash Flow	-$53.34M	-$65.89M	-$59.44M
YoY Change	414.38%	10.87%	108.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q4	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	dei	Security12b Title Security12bTitle	Common Stock
CY2022Q4	dei	Entity Central Index Key EntityCentralIndexKey	0001581280
CY2022Q4	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2022Q4	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2022Q4	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2022Q4	dei	Document Type DocumentType	10-Q
CY2022Q4	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2022Q4	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022Q4	dei	Document Transition Report DocumentTransitionReport	false
CY2022Q4	dei	Entity File Number EntityFileNumber	001-38720
CY2022Q4	dei	Entity Registrant Name EntityRegistrantName	Twist Bioscience Corporation
CY2022Q4	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022Q4	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	46-2058888
CY2022Q4	dei	Entity Address Address Line1 EntityAddressAddressLine1	681 Gateway Blvd
CY2022Q4	dei	Entity Address City Or Town EntityAddressCityOrTown	South San Francisco
CY2022Q4	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022Q4	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94080
CY2022Q4	dei	City Area Code CityAreaCode	800
CY2022Q4	dei	Local Phone Number LocalPhoneNumber	719-0671
CY2022Q4	dei	Trading Symbol TradingSymbol	TWST
CY2022Q4	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022Q4	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022Q4	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022Q4	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2022Q4	dei	Entity Small Business EntitySmallBusiness	false
CY2022Q4	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2022Q4	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56858200	shares
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316681000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	378687000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	122029000	usd
CY2022Q3	us-gaap	Short Term Investments ShortTermInvestments	126281000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44437000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40294000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	44597000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	39307000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	14115000	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	11914000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	541859000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	596483000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144850000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139441000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73757000	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	74948000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	85811000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58361000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59738000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2410000	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1572000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2922000	usd
CY2022Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	3385000	usd
CY2022Q4	us-gaap	Assets Assets	909970000	usd
CY2022Q3	us-gaap	Assets Assets	961378000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	20113000	usd
CY2022Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	20092000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10398000	usd
CY2022Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	10169000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23277000	usd
CY2022Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	27023000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14227000	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	13642000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15822000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	19737000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	83837000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	90663000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79748000	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	81270000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	60000	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	60000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	163645000	usd
CY2022Q3	us-gaap	Liabilities Liabilities	171993000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56645000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56645000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	56523000	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56523000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	0	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1617174000	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1619644000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-609000	usd
CY2022Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1843000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-870240000	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-828416000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	746325000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	789385000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	909970000	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	961378000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54243000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	42018000	usd
CY2022Q4	us-gaap	Cost Of Revenue CostOfRevenue	29442000	usd
CY2021Q4	us-gaap	Cost Of Revenue CostOfRevenue	27056000	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	31242000	usd
CY2021Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22630000	usd
CY2022Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	42324000	usd
CY2021Q4	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	51098000	usd
CY2022Q4	twst	Change In Fair Value Of Contingent Consideration And Indemnity Holdback ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback	4135000	usd
CY2021Q4	twst	Change In Fair Value Of Contingent Consideration And Indemnity Holdback ChangeInFairValueOfContingentConsiderationAndIndemnityHoldback	2826000	usd
CY2022Q4	us-gaap	Costs And Expenses CostsAndExpenses	98873000	usd
CY2021Q4	us-gaap	Costs And Expenses CostsAndExpenses	97958000	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-44630000	usd
CY2021Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-55940000	usd
CY2022Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	3040000	usd
CY2021Q4	us-gaap	Investment Income Interest InvestmentIncomeInterest	154000	usd
CY2022Q4	us-gaap	Interest Expense InterestExpense	1000	usd
CY2021Q4	us-gaap	Interest Expense InterestExpense	26000	usd
CY2022Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-157000	usd
CY2021Q4	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-156000	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-41748000	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56444000	shares
CY2021Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55968000	usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	76000	usd
CY2021Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10405000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-41824000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-45563000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-868000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	277000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-366000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-94000	usd
CY2022Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43058000	usd
CY2021Q4	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-45380000	usd
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56444000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49912000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49912000	shares
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	789385000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	603000	usd
CY2022Q4	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	0	usd
CY2022Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	999000	usd
CY2022Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	-2074000	usd
CY2022Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	1234000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-41824000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	746325000	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	580821000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3039000	usd
CY2021Q4	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	72514000	usd
CY2021Q4	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	2558000	usd
CY2021Q4	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	18108000	usd
CY2021Q4	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-183000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-45563000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	626178000	usd
CY2022Q4	us-gaap	Profit Loss ProfitLoss	-41824000	usd
CY2021Q4	us-gaap	Profit Loss ProfitLoss	-45563000	usd
CY2022Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5292000	usd
CY2021Q4	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3150000	usd
CY2022Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	0	usd
CY2021Q4	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	10545000	usd
CY2022Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	254000	usd
CY2021Q4	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	1174000	usd
CY2022Q4	us-gaap	Share Based Compensation ShareBasedCompensation	-2325000	usd
CY2021Q4	us-gaap	Share Based Compensation ShareBasedCompensation	18108000	usd
CY2022Q4	twst	Change In Fair Value Of Acquisition Consideration ChangeInFairValueOfAcquisitionConsideration	-4135000	usd
CY2021Q4	twst	Change In Fair Value Of Acquisition Consideration ChangeInFairValueOfAcquisitionConsideration	-2826000	usd
CY2022Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-287000	usd
CY2021Q4	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-395000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4098000	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2032000	usd
CY2022Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5281000	usd
CY2021Q4	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	8436000	usd
CY2022Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1177000	usd
CY2021Q4	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	91000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-499000	usd
CY2021Q4	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3231000	usd
CY2022Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3282000	usd
CY2021Q4	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-5000	usd
CY2022Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1254000	usd
CY2021Q4	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	445000	usd
CY2022Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3716000	usd
CY2021Q4	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-3624000	usd
CY2022Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	126000	usd
CY2021Q4	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-34000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54070000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-46653000	usd
CY2022Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11824000	usd
CY2021Q4	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	12783000	usd
CY2022Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2021Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8160000	usd
CY2022Q4	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	22647000	usd
CY2021Q4	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	217639000	usd
CY2022Q4	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	27500000	usd
CY2021Q4	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	12000000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6971000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-226582000	usd
CY2022Q4	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	604000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	3105000	usd
CY2022Q4	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	0	usd
CY2021Q4	us-gaap	Proceeds From Repayments Of Debt ProceedsFromRepaymentsOfDebt	-1558000	usd
CY2022Q4	twst	Payments To Repurchases Of Common Stock For Tax Withholding PaymentsToRepurchasesOfCommonStockForTaxWithholding	999000	usd
CY2021Q4	twst	Payments To Repurchases Of Common Stock For Tax Withholding PaymentsToRepurchasesOfCommonStockForTaxWithholding	2558000	usd
CY2022Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-395000	usd
CY2021Q4	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1011000	usd
CY2022Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	268000	usd
CY2021Q4	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-61168000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-274163000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	380259000	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	467359000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	319091000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	193196000	usd
CY2022Q4	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2021Q4	us-gaap	Interest Paid Net InterestPaidNet	9000	usd
CY2022Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	52000	usd
CY2021Q4	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	91000	usd
CY2022Q4	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	4520000	usd
CY2021Q4	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	11479000	usd
CY2022Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2021Q4	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	10423000	usd
CY2022Q4	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2021Q4	us-gaap	Stock Issued1 StockIssued1	72514000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-870200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316681000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	378687000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	2410000	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1572000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	319091000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	380259000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	316681000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	316681000	usd
CY2022Q4	twst	Cash And Cash Equivalents And Short Term Investments Amortized Cost CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost	439436000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	726000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	438710000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	378687000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	234000	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents Fair Value Disclosure CashAndCashEquivalentsFairValueDisclosure	378687000	usd
CY2022Q3	twst	Cash And Cash Equivalents And Short Term Investments Amortized Cost CashAndCashEquivalentsAndShortTermInvestmentsAmortizedCost	506562000	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2022Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1594000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	504968000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	376225000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	7557000	usd
CY2022Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	7557000	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	443086000	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability BusinessCombinationContingentConsiderationLiability	11692000	usd
CY2022Q3	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	11692000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2100000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-2100000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2100000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	222000	usd
CY2022Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2100000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-2100000	usd
CY2022Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	0	usd
CY2022Q4	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	39405000	usd
CY2022Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	35706000	usd
CY2022Q4	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	5254000	usd
CY2022Q3	us-gaap	Other Receivables Gross Current OtherReceivablesGrossCurrent	4822000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	44437000	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	40294000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	33558000	usd
CY2022Q3	us-gaap	Inventory Raw Materials InventoryRawMaterials	28787000	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	3610000	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	2866000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7429000	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7654000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	44597000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	39307000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	0	usd
CY2022Q3	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	100000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	180539000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	171218000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	35689000	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	31777000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	144850000	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	139441000	usd
CY2022Q4	twst	Business Combination Indemnity Holdbacks Current BusinessCombinationIndemnityHoldbacksCurrent	7557000	usd
CY2022Q3	twst	Business Combination Indemnity Holdbacks Current BusinessCombinationIndemnityHoldbacksCurrent	9592000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	3761000	usd
CY2022Q3	us-gaap	Taxes Payable Current TaxesPayableCurrent	3661000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3683000	usd
CY2022Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	3476000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2022Q3	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	2100000	usd
CY2022Q4	twst	Other Liabilities Current Other Than Contingent Consideration And Taxes OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes	821000	usd
CY2022Q3	twst	Other Liabilities Current Other Than Contingent Consideration And Taxes OtherLiabilitiesCurrentOtherThanContingentConsiderationAndTaxes	908000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	15822000	usd
CY2022Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	19737000	usd
CY2022Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1400000	usd
CY2021Q4	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	800000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2021Q3	us-gaap	Goodwill Goodwill	22434000	usd
CY2022Q4	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	61768000	usd
CY2022Q4	us-gaap	Goodwill Subsequent Recognition Of Deferred Tax Asset GoodwillSubsequentRecognitionOfDeferredTaxAsset	0	usd
CY2022	us-gaap	Goodwill Subsequent Recognition Of Deferred Tax Asset GoodwillSubsequentRecognitionOfDeferredTaxAsset	1609000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	85811000	usd
CY2022Q3	us-gaap	Goodwill Goodwill	85811000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	66130000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	7769000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	58361000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	66130000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6392000	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	59738000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	73757000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14227000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79748000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	11981000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	14214000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	14066000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	12609000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	7265000	usd
CY2022Q4	twst	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	90968000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	151103000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	57128000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	93975000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14227000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	79748000	usd
CY2022Q4	twst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	1200000	usd
CY2022Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	900000	usd
CY2021Q4	twst	Increase Decrease In Operating Lease Right Of Use Asset IncreaseDecreaseInOperatingLeaseRightOfUseAsset	10400000	usd
CY2021Q4	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	11600000	usd
CY2022Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	4100000	usd
CY2021Q4	us-gaap	Operating Lease Expense OperatingLeaseExpense	3500000	usd
CY2022Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	3600000	usd
CY2021Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	2900000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y10M24D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.064
CY2022Q4	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	2100000	usd
CY2021Q4	us-gaap	Related Party Transaction Purchases From Related Party RelatedPartyTransactionPurchasesFromRelatedParty	1700000	usd
CY2022Q4	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	200000	usd
CY2021Q4	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	0	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	700000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	200000	usd
CY2021Q4	us-gaap	Accounts Receivable Related Parties AccountsReceivableRelatedParties	0	usd
CY2021Q4	us-gaap	Accounts Payable Related Parties Current And Noncurrent AccountsPayableRelatedPartiesCurrentAndNoncurrent	0	usd
CY2022	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	100000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	twst	Common Stock Number Of Votes Per Share CommonStockNumberOfVotesPerShare	1	vote
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2453000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.67
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y3M29D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33447000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	37000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	42.87
CY2022Q4	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	35000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	17.17
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	312000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2381000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	24.49
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y21D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	10715000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	427000	shares
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	33.87
CY2022Q4	twst	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedWeightedAverageRemainingContractualTerm	P6Y11M1D
CY2022Q4	twst	Share Based Compensation Arrangement By Share Based Payment Award Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsNonvestedIntrinsicValue	423000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1954000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	22.44
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M13D
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10292000	usd
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	9400000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2325000	usd
CY2021Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	18068000	usd
CY2022Q4	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	-2300000	usd
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	56444000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	49912000	shares
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	507000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	250000	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	0	shares
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	757000	shares
CY2022Q4	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2022Q4	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2022Q4	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	700000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-41824000	usd
CY2021Q4	us-gaap	Net Income Loss NetIncomeLoss	-45563000	usd
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	56444000	shares
CY2021Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49912000	shares
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.74
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.74
CY2021Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.91
CY2021Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.91
CY2022Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5407000	shares
CY2021Q4	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4583000	shares
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54243000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	42018000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54243000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	42018000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54243000	usd
CY2021Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	42018000	usd

Files In Submission

Name	View Source	Status
0001628280-23-002560-index-headers.html	Edgar Link	pending
0001628280-23-002560-index.html	Edgar Link	pending
0001628280-23-002560.txt	Edgar Link	pending
0001628280-23-002560-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
image_0a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
twst-20221231.htm	Edgar Link	pending
twst-20221231.xsd	Edgar Link	pending
twst-20221231x10qxex311.htm	Edgar Link	pending
twst-20221231x10qxex312.htm	Edgar Link	pending
twst-20221231x10qxex321.htm	Edgar Link	pending
twst-20221231x10qxex322.htm	Edgar Link	pending
twst-20221231xxex101employ.htm	Edgar Link	pending
twst-20221231_g1.jpg	Edgar Link	pending
twst-20221231_cal.xml	Edgar Link	unprocessable
twst-20221231_def.xml	Edgar Link	unprocessable
twst-20221231_lab.xml	Edgar Link	unprocessable
twst-20221231_pre.xml	Edgar Link	unprocessable
twst-20221231_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$TWST
Twist Bioscience Corp Stock $twst

2023 Q1 Form 10-Q Financial Statement

#000162828023002560 Filed on February 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TWST Twist Bioscience Corp Stock $twst

2023 Q1 Form 10-Q Financial Statement

#000162828023002560 Filed on February 07, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$TWST
Twist Bioscience Corp Stock $twst